Swiss generics and biosimilars major Sandoz (SIX: SDZ) today presented its net sales update for the first quarter of 2025.

In a recent study conducted by Navaneethan and colleagues and published in the International Society of Nephrology, the ...

US-Ireland drugmaker Shorla Oncology has received approval from the US regulator for a new multi-dose vial of Tepylute ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) today announced financial results for the first quarter of 2025, showing ...

The European Commission has approved the conversion of the conditional marketing approval (CMA) into a standard marketing ...